Bristol-Myers Squibb Divests Imaging Agents, Considers Sale Of ConvaTec
This article was originally published in The Gray Sheet
Executive Summary
Bristol-Myers Squibb is evaluating strategic alternatives for its ConvaTec ostomy and wound care device business following the divestiture of its imaging agent franchise, announced Dec. 17